MedPath

Urodynamic Testing: Can we Improve Patient Experience?

Not Applicable
Completed
Conditions
Urinary Bladder, Overactive
Urinary Incontinence
Lower Urinary Tract Symptoms
Interventions
Other: Preprocedure Telephone Call
Registration Number
NCT02742389
Lead Sponsor
Boston Urogynecology Associates
Brief Summary

The purpose of this study is to determine whether an intervention (pre-procedure telephone call by the investigators) will reduce anxiety in women undergoing urodynamic testing (UDT) compared to usual care. Our hypothesis is that women who receive the intervention will report less anxiety immediately before UDT than women who receive usual care.

Detailed Description

This is a non-blinded, randomized controlled trial. The clinical trial will investigate whether a telephone call by the investigator one week prior to urodynamic testing (UDT) will decrease patient pre-procedure anxiety, improve patient-reported preparedness and increase satisfaction compared to usual care. Patients who are scheduled for UDT will be informed about the study. If the patient agrees to participate in the study, she will be randomized to one of 2 groups based on the week of her scheduled UDT.

Group 1: Standard counseling. This group will receive the standard counseling that all Boston Urogynecology Associates (BUA) patients would receive if they are scheduled to have urodynamic testing. This counseling will include a description of the procedure and a handout about urodynamic testing. On the day of their test the participants will be asked to complete a brief survey about their experience before and after their testing. The investigators will also collect some information from their medical record, such as age and prior urogynecologic procedures.

Group 2: Standard counseling plus the intervention. The participants assigned to be in the intervention group will receive the standard counseling that all BUA patients who are scheduled for urodynamic testing receive (just like those who are assigned to group 1). This counseling includes a description of the procedure and a handout about urodynamic testing. In addition, the participants will receive a phone call from the investigators 1 week before their testing to talk about the procedure. The investigator calling the participant will document the duration of the phone call and any questions asked by the participant. On the day of their test the participants will be asked to complete the same surveys as group 1.

Surveys given to the participants on the day of their UDT appointment will include:

1. A pre-UDT questionnaire that includes questions on demographics, overall anxiety, anxiety about specific elements of procedure, self-reported preparedness and satisfaction.

2. A brief post-UDT questionnaire addressing test experience and pain.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
130
Inclusion Criteria
  1. 18 years or greater
  2. Female
  3. Patients who have decided to schedule Urodynamic Testing to follow-up lower urinary tract dysfunction, pelvic organ prolapse, and/or urinary incontinence
Exclusion Criteria
  1. Pregnant
  2. Presence of indwelling catheters
  3. History of prior Urodynamic Testing

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Standard + Preprocedure Telephone CallPreprocedure Telephone CallThe participants will receive the standard counseling that all our patients who are scheduled for urodynamic testing receive (just like those who are assigned to group 1). In addition, the participants will receive intervention: a pre-procedural telephone call from the investigators 1 week before their testing to talk about the procedure.
Primary Outcome Measures
NameTimeMethod
Overall pre-procedure anxiety as measured on a visual analog scale.Day 1

Overall pre-procedure anxiety as measured on a visual analog scale.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Mount Auburn Hospital

🇺🇸

Cambridge, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath